Close Menu

NEW YORK (360Dx) – The US Preventive Services Task Force said today that men aged 55 to 59 should decide with their clinicians whether to pursue prostate specific antigen-based cancer screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.